Combining UBR5 and CD163+ tumor-associated macrophages better predicts prognosis of clear cell renal cell carcinoma patients

Chao Wang,TianYu Hong,Yuning Wang,Guang Peng,Yongwei Yu,Jing Zhang,Dong Zhuo,Jingcun Zheng,Xiaojing Ma,Xingang Cui
DOI: https://doi.org/10.1007/s00262-021-02885-9
2021-03-12
Abstract:Identification of reliable postoperative indicators for accurately evaluating prognosis of clear cell renal cell carcinoma (ccRCC) patients remains an important clinical issue. This study determined the prognostic value of UBR5 expression in ccRCC patients by combining with CD163<sup>+</sup> tumor-associated macrophages (TAMs) and the established clinical parameters.
oncology,immunology
What problem does this paper attempt to address?